Center for Global Health R&D Policy Assessment

Featured Blog Post

Addressing the “1-99” gap: a new generation of antipoverty vaccines for neglected diseases

A Guest Blog by Dr. Peter Hotez

The term “10-90 gap” has been used to describe a tragic reality that fewer than 10% of the world’s resources for research and development (R&D) are available for the conditions and diseases affecting 90% of the world’s population – that which is disproportionately represented by people living in low-income countries.